Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Johnson & Johnson, Imerys may face more suits related to baby powder, Reuters Says

Monday, April 16, 2018 6:17
% of readers think this story is Fact. Add your two cents.

Johnson & Johnson (NYSE:JNJ) and talc supplier Imerys SA may face thousands of lawsuits related to J&J’s Baby Powder after a court last week ruled in favor of a man who claimed his asbestos-related cancer was caused by use of the product, Reuters reported, citing legal experts and attorneys.

A New Jersey state court ruled the companies will have to pay out a total of $117 million to the man. Plaintiffs lawyers claim that internal J&J documents seen in that trial reveal that baby powder had been contaminated with asbestos, the report said. They plan to use the documents in upcoming ovarian cancer trials to allege that the asbestos contamination also caused that form of cancer, Reuters reported.

J&J and Imerys Talc America, a unit of Imerys, have said they plan to appeal the verdict and deny asbestos has ever been present in their products or that their talc can cause any form of cancer.

 

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/195059/johnson-johnson-imerys-may-face-more-suits-related-to-baby-powder-reuters-says-195059.html

We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

Loading...

Top Global

Top Alternative

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.